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Mobile DNAs have had a central role in shaping our genome.More than half of our DNA is comprised
of interspersed repeats resulting from replicative copy and paste events of retrotransposons.
Althoughmost are fixed, incapable of templating new copies, there are important exceptions to ret-
rotransposon quiescence. De novo insertions cause genetic diseases and cancers, though reliably
detecting these occurrences has been difficult. New technologies aimed at uncovering polymor-
phic insertions reveal that mobile DNAs provide a substantial and dynamic source of structural vari-
ation. Key questions going forward include how and how much new transposition events affect
human health and disease.Human Retroelements
High copy number repeats reflecting mobile DNA integrations
comprise a large fraction of genomes in a wide variety of organ-
isms. The proportions of mobile DNAs in genomes are highly
variable among species, and each eukaryote has a specific
complement of recently active transposable elements (TEs).
Transposons are thus key genetic features distinguishing related
species.
Humans are no exception. Likemost other mammals, the land-
scape of our genome reflects a long history of activity of retro-
transposons known as class I transposable elements. These
elements replicate by a copy and paste mechanism, producing
mRNA-like intermediates that are reverse transcribed by an
element-encoded enzyme. In contrast, class II DNA transposons
employ a cut and paste mechanism, directly moving DNA
segments from one location to another. Although DNA transpo-
sons are not active in humans, a co-opted DNA cut and paste
system is involved in recombination events that generate lympho-
cyte antigen binding diversity (Agrawal et al., 1998). The retro-
transposons that have recently made significant contributions to
the human genome include long and short interspersed repeats
(termed LINEs and SINEs, respectively) and long terminal repeat
elements (LTR elements). In the current genome assembly, about
45% of our total DNA is recognizable as having homology to
consensus sequences of retroelements (Figure 1A) (Jurka et al.,
2005; Lander et al., 2001; Smit et al., 1996). The true contribution
of retroelements to the human genome is likely to be considerably
larger. A newcomputational approach reliant on de novo recogni-
tionofhigh-abundanceoligonucleotides recognizesmanysmaller
fragments of elements accrued over hundreds of millions of years
of vertebrate evolution and estimates that repeats comprise
nearly two-thirds of our total genome (de Koning et al., 2011).
A relatively recent, or ‘‘young,’’ transposon insertion sequence
bears high homology to currently active template elements; older740 Cell 149, May 11, 2012 ª2012 Elsevier Inc.insertions accrue changes resulting in divergence of their
sequences from the family consensus (Figure 1C). Although
rates vary, in humans, sequence divergence of interspersed
repeats of about 12%–18% has occurred over the last 100
million years (Lander et al., 2001). L1 LINEs and Alu SINEs
date to about 150 and 80 million years, respectively, and were
preceded by expansions of L2 LINEs andMIR SINEs. In contrast,
currently active retrotransposons include a subset of L1 with
about 0.8% divergence from the consensus and elements it
mobilizes. When a L1 LINE, SINE, or SVA retrotransposon inser-
tion occurs in or is passed to the germline, the locus can be
inherited with it present or absent; these are colloquially referred
to as the ‘‘filled’’ versus ‘‘empty’’ alleles. The empty allele ante-
dates the insertion event; it is the ancestral allele. If autosomal,
an insertion may be homozygous or heterozygous in an indi-
vidual. Suchpolymorphic insertions are categorized as a subtype
of ‘‘indel’’ structural variants, though no deletion event is relevant
for these non-LTR retrotransposons. We consider these as bial-
lelic polymorphisms herein, disregarding subsequent nucleotide
changes within the inserted sequence for simplicity.
Most of the repetitive landscape of our genome reflects inte-
gration events that became homozygous in ancestral species.
Species-specific insertions are responsible for a minor though
notable portion of the difference between our genome and that
of the common chimpanzee, Pan troglodytes (Hedges et al.,
2004; The Chimpanzee Sequencing and Analysis Consortium,
2005; Mills et al., 2006). In total, transposable element insertions
are responsible for about 16Mb of sequence difference in a pair-
wise comparison of the genomes; that amounts to 0.5% of either
genome. For context,35 million nucleotide substitutions (1.2%
of either genome) distinguish the species. Since divergence,
humans and chimps have accrued similar numbers of species-
specific L1 and SVA inserts, whereas humans accumulated
nearly three times as many Alu elements. The human genome
Figure 1. Human Retrotransposons
(A) Composition of the human genome with respect to high copy number
repeats. Data are from the RepeatMasker analysis of the hg19 human genome
assembly (Genome Reference Consortium GRCh37). The illustration shows
fractions of the genome derived from the major orders (Wicker et al., 2007) of
retrotransposons. The remaining 55% of the genome bears low homology to
TEs, although substantial portions may be derived from mobile DNA.
(B) Transposon types illustrated as fractions of total ongoing activity. AluY are
themost prolific source of new insertions at 1 de novo germline insertion per 20
births; L1 and SVA are thought to be comparable in current activity, respon-
sible for 1 insertion per 100–200 births.
(C) Schematic showing an accumulation of interspersed repeat insertions over
time. New integrations are stochastic events in individuals (star), such that
coexistence with the antedating empty allele occurs in the population initially.
In the schematic, two alleles are present currently, reflecting presence and
absence of the most recent insertion (a retrotransposon insertion poly-
morphism [RIP]). As persisting insertions age, they become fixed, or invariant,
in the population and decrease in sequence likeness to similar elements (black
to gray).
(D) Structure of the most active retroelements in human genomes. L1 LINEs
have a CpG-rich 50 UTR with an internal RNA Pol II promoter (50 rightward
arrow), two open reading frames encoding ORF1p and ORF2p (orange
segments), and a 30 UTR with a polyadenylation (pA) sequence. The ORF2
reading frame encodes endonuclease (EN) and reverse transcriptase (RT)
domains. Alu elements are derived from 7SL ribosomal RNAs; they have two
internal monomer sequences with a centrally located A-rich sequence and an
RNA Pol III promoter (A and B, gray). The sequence ends in multiple adeno-
sines (An). SVAs are composites of other repeats, from left to right: a CCCTCTn
repeat, two tandem Alu-like sequences in antisense (leftward arrows), a vari-
able number tandem repeat (VNTR) region, and a SINE-R region with HERV
homology. Sequence suggests RNA Pol II-driven transcription (50 rightward
arrow), and there is a 30 AAUAAA sequence (pA).
Figure 2. L1 LINE Propagation
L1 retrotransposition requires RNA and two proteins encoded by L1; they
assemble into ribonucleic acid particles during translation. Reverse tran-
scription of the RNA is coupled to insertion as it initiates from the 30-OH of the
broken strand (target primed reverse transcription, TPRT). Resolution of the
structure results in target site duplication (TSD).contains 2000 species-specific LINEs (L1), 8,000 species-
specific inserts of dependent elements (7,000 Alu and 1,000
SVA), and 73 LTRs (mostly HERV-K solo LTRs). For each type,
a limited repertoire of recently active transposon subfamilies is
responsible for the expansion in humans. Subfamilies are
defined by internal transposon sequence, as described further
below. For example, AluYa5 and AluYb8 subfamilies predomi-
nate among human-specific SINEs; L1HS are chiefly responsible
for LINEs unique to humans.
There are three highly active human retrotransposon families
today (Figures 1B and 1D). All require a combination of host
factors and proteins encoded by L1 LINEs to continuously
re-enter our genomes (see Ostertag and Kazazian, 2001a for
a review of human L1), and thus L1 transposons are termed
the autonomous elements. A full-length L1 is 6 kilobases long.
Following transcription by RNA polymerase II, translation of the
two open reading frames occurs, producing ORF1p and
ORF2p. Association of the L1 transcript with these proteins
occurs in ribonucleic acid particles (RNPs) (Hohjoh and Singer,
1996), and cis preference is seen for these interactions (Kulpa
and Moran, 2006; Wei et al., 2001). ORF1p is required for L1
transposition and functions as a chaperone protein or single-
strand RNA-binding protein (reviewed in Martin, 2010). ORF2p
has two recognized enzymatic domains, an endonuclease
(Feng et al., 1996) and reverse transcriptase (Mathias et al.,
1991). L1 retrotransposition is diagrammed in Figure 2. The
ORF2p-encoded endonuclease mediates a DNA nick in the
host genome, and the resulting 30-OH is extended by the reverse
transcriptase to make a nuclear DNA copy of the L1 RNA
template; this is termed target primed reverse transcription
(TPRT). The precise steps for resolution of this structure are
not known, although the breakpoint of the second DNA strandCell 149, May 11, 2012 ª2012 Elsevier Inc. 741
is staggered such that a small sequence of the target site is
duplicated flanking the insertion. The second strand appears
capable of annealing internally in the L1 RNA and initiating
a second RT reaction, a process termed twin priming. This can
result in inversions and truncations of 50 L1 sequence and may
be responsible for the preponderance of L1 insertions that
have lost 50 sequence (Ostertag and Kazazian, 2001b). In vitro
assays using a recombinant transposon have been essential to
identifying critical sequences that are required for transposition
(reviewed in Rangwala and Kazazian, 2009). These place
a marker cassette in antisense orientation with respect to the
transposon; it is interrupted by an intron spliced in sense, such
that cells with an integration event acquire a functional marker.
Similar systems can be used for Alu insertions (Dewannieux
et al., 2003) or introduced in transgenic mice to provide a system
for studying host control (An et al., 2006; Heidmann and Heid-
mann, 1991; Ostertag et al., 2002).
In primates, Alu elements co-opt L1 machinery (Dewannieux
et al., 2003), and their de novo insertion rate has rivaled or
exceeded that of L1 (Cordaux et al., 2006; Shen et al., 1991;
see Batzer and Deininger, 2002 for a review of Alu). Alu SINEs
are named for an internal AluI restriction enzyme recognition
site (Houck et al., 1979). Like SINEs in other species, Alu
elements are derived from pre-existing cellular RNAs, originating
from the 7SL ribosome complex (Ullu and Weiner, 1984). Alu
sequences are transcribed by RNA polymerase III, which recog-
nizes an internal 50 promoter as well as external sequences
and reads through beyond the element 30 poly(A) end (Ullu and
Weiner, 1985). Alu elements are about 300 bp in length and
have two distinct internal ‘‘monomer’’ sequences with a centrally
located A-rich sequence (A5TACA6) (Figure 1D). They interact
with L1-encoded ORF2p during insertion so as to leave a target
site duplication, and L1 ORF1p is dispensable for Alu mobiliza-
tion (Dewannieux et al., 2003).
A third family of active retrotransposons in humans is termed
SVA for their multipartite structure reflecting SINE-R, VNTR,
and Alu components (see Hancks and Kazazian, 2010 for
a review of SVA). SVA are mobilized by L1 proteins (Hancks
et al., 2011; Raiz et al., 2011). Compared to L1 and Alu, SVAs
are structurally more heterogeneous; they range in size from
700 bp to 4 kb, with a canonical 2 kb element (Figure 1D).
SVAs also exhibit more RNA complexity, with numerous splice
isoforms capable of retrotransposition and a strong propensity
to relocate neighboring 50 or 30 sequence during transposition,
incorporating this in the SVA RNA by upstream transcript initia-
tion or poly(A) readthrough. Compared to other active repeats,
they constitute a small amount of our total DNA; there are about
3,700 intervals in our genome with homology to SVA (Jurka,
2000; Smit et al., 1996).
Human LTR retroelements consist of three classes of endog-
enous proviruses, class I (gamma retroviruses), class II (beta
retroviruses), and class III (spuma retroviruses) (Mager and
Medstrand, 2003). Full-length human endogenous retrovirus
(HERV) elements structurally resemble exogenous retroviruses,
with recognizable gag, pol, and, in some cases, env genes. Frag-
ments are also frequently found in the genome as single, or
‘‘solo,’’ LTRs. These result from insertion followed by a recombi-
nation between the long terminal repeats, which deletes the742 Cell 149, May 11, 2012 ª2012 Elsevier Inc.intervening proviral sequences. The mechanism of LTR transpo-
sition is completely independent of L1, and ERVs may be trans-
mitted horizontally. HERV elements are named with single-letter
amino acid abbreviations denoting the host tRNA co-opted as
a primer for reverse transcription (Cohen and Larsson, 1988).
Human endogenous retroviruses are transpositionally inert,
with the possible exception of HERV-K (HML2), a family of
class II elements. HERV-K (HML2) proviruses that are capable
of templating infectious particles and new insertions have not
been found, although they can be reconstituted by recombining
together sequences from existing elements (Dewannieux et al.,
2006; Lee and Bieniasz, 2007). One of the best pieces of
evidence for recent HERV-K activity is that polymorphic
elements persist in human populations (i.e., there are loci in
which an individual may carry an empty allele, a solo LTR allele,
and/or a full-length proviral insertion allele) (Moyes et al., 2007).
Hiding in the Haystack: Identifying Retroelements
in the Genome
For most geneticists, genomic repeats are nuisances—
sequences of extraordinarily high copy number that overwhelm
hybridization-based assays, introduce artifacts in PCR amplifi-
cations, and generate unmappable reads. Historically, our
appreciation for the importance of polymorphic repeats has
lagged behind other areas of genomics. Today, this view is
changing rapidly as investigators target polymorphisms for
sequencing or tailor sequence analysis pipelines for transposon
discovery.
Approaches for targeted recovery of insertion sites of young
repeat subfamilies, which are most likely to be polymorphic,
have been PCR-based methods also known as ‘‘hemispecific’’
or ‘‘one-sided’’ amplifications. They amplify known (repeat)
sequence and neighboring, unique DNA sequence. The reac-
tions gain specificity by exploiting internal repeat sequences
that are characteristic of recently expanding subfamilies. For
human L1, this means two or three contiguous nucleotides in
the 30 UTR of the element characteristic of the pre-Ta and Ta
subsets, respectively (Ta, for transcribed subset a) (Skowronski
et al., 1988) (Figure 3A). This allows selective amplification of L1
insertion sites that date from about 2 million years ago and are
partly polymorphic in human populations (Myers et al., 2002)
while preventing amplification of older ‘‘fixed present’’ L1 inser-
tions, which outnumber intended targets nearly a thousand fold.
Examples of these approaches include subtractive suppression
PCR (Badge et al., 2003; Buzdin et al., 2003), random decamer
PCR (Sheen et al., 2000), and ligation-mediated PCR (Porntha-
nakasem and Mutirangura, 2004). These ‘‘first-generation’’
methods reduced the complexity of amplicons so that L1
insertion variants could be identified by electrophoresis by
suppressing recovery of L1(Ta)s shared between samples
and/or imposing limits on adjacent sequences. These methods
successfully identified small numbers of polymorphic insertions.
Advances in genomic technologies have led to far more
comprehensive methods for discovering retrotransposon
insertion polymorphisms (RIPs). For L1 insertion mapping, liga-
tion-mediated PCR known as vectorette PCR can be used to
comprehensively recover L1(Ta) subset insertions in the human
genome. The amplicons begin near one transposon end and
Figure 3. Sequence Signatures of Active Elements
(A) Families of L1 LINEs have expanded over evolutionary time in primate genomes in a singular succession of retrotransposition ‘‘waves’’; that is, elements have
accumulated in a specific order, with L1PA5 insertions preceding L1PA4 preceding L1PA3, L1PA2, and L1PA1 (Boissinot and Furano, 2001). For the last 2 million
years, continued L1 activity is largely owed to the L1(Ta) subset (L1PA1). A 3 nt sequence in the 30 UTR of L1(Ta) can be used to physically distinguish its members
from sequences of older L1 LINEs in the human genome; this can lend specificity to L1(Ta)-mapping PCRs.
(B) Similarly, an 8 base-pair insertion near the 30 end of AluYb8/9 subfamilies can be used to specifically recover insertion sites of these elements.extend to adjacent, mappable DNA sequence. The resulting
complex mixture of PCR products can be resolved by either
hybridization to genomic tiling microarrays (transposon insertion
profiling by microarray, TIP-chip [Huang et al., 2010; Wheelan
et al., 2006]) or next-generation sequencing (TIP-seq). Different
PCR methods have also been used in tandem with next-genera-
tion sequencing methods for L1 mapping (Ewing and Kazazian,
2010; Iskow et al., 2010). Comprehensive L1(Ta) profiling of an
individual by TIP-chip encompassed 323 insertions included in
the reference genome and uncovered 191 novel candidate
insertions (Huang et al., 2010). Many previously unreported L1
insertion positions could then be verified by site-specific PCR
and the precise insertion site shown by Sanger sequencing.
Whole-genome L1(Ta) insertion profiles of 15 individuals using
TIP-chip indicated a predilection for insertions in AT-rich regions
and no evidence of insertions strongly targeting or avoiding
particular gene loci or chromosomes. Although SINEs are more
prevalent in genomes and more heterogeneous in terms of
active families, mapping Alu insertions is tractable to similar
approaches. These have included TIP-chip applications for
AluYa and AluYb (Huang et al., 2010), linker-mediated PCRs
with amplicon sequencing for AluYa (Iskow et al., 2010), and
AluYb8/9 insertion recovery by a ligation-mediated PCR termed
mobile element scan (ME-scan) (Witherspoon et al., 2010). ME-
scan includes a hybridization-based purification of desired
AluYb8/9-containing fragments followed by their amplification.
AluYb insertion sites lend themselves especially well to family-
specific amplification, as they have an eight base-pair insertion
very close to the 30 element end (Figure 3B). Finally, an array
hybridization-based enrichment termed retrotransposon
capture sequencing (RC-seq) has been recently reported and
applied to somatic insertion discovery, as we consider further
below (Baillie et al., 2011).
Genomic-scale approaches for polymorphism discovery are
highly effective and will have special utility for clinical hypothesis
testing in the future. However, they have been quickly outpacedby in silico computational methods for general cataloging of
common repeat polymorphisms. By in silico methods, we
mean that computational pipelines rather than sequencing
methods are tailored for repeat discovery. These studies include,
for example, two published comparisons of genome assemblies:
a pairwise analysis of the Human Genome Project hg17
assembly versus the Celera build, as reported by Konkel et al.
(2007), and more recently, an hg18 comparison to Venter HuRef
by Xing et al. (2009). Xing et al. considered all major transposon
families in their analysis and identified 584HuRef-specificAlu, 52
L1, and 14 SVA insertions, in general agreement with the
numbers of polymorphic L1 described in the study by Konkel
and colleagues. These tallies underscore how much any indi-
vidual varies from the reference genome. The numbers are
dwarfed by the RIPs being found in sequencing projects that
are designed to capture human genetic diversity. The original
study of 36 International HapMap project samples provided an
early indication that such approaches would be fruitful, returning
hundreds of new mobile element insertions by recognizing
repeat homologies in sequences proximal to putative indel sites
(Bennett et al., 2004). Today, the 1000 Genomes project has
provided the single richest source of new RIPs (Stewart et al.,
2011). Stewart et al. described polymorphic repeats in about
180 individual genomes using two types of data sets, paired-
end short read sequences (Illumina) and longer sequences that
were bisected for analysis (Roche/454). Novel RIPs were called
as clusters of sequence fragments in which one end showed
mobile element homology while the other end was uniquely
mappable to the reference assembly a sufficient distance away
from known reference elements. In a separate complementary
analysis, reference elements were deemed polymorphic if
evidence of an empty allele was found. This identified 6,229 poly-
morphic Alus (4,499 nonreference), 998 polymorphic L1s (792
nonreference), and 153 variant SVAs (79 nonreference). The L1
number is in fairly good agreement with an independently devel-
oped algorithm from an analysis of 307 individual genomesCell 149, May 11, 2012 ª2012 Elsevier Inc. 743
Figure 4. A Schematic of Retrotransposon
Dynamics
(A) An L1 insertion of moderate activity (blue) and
allelic frequency (circle size) is shown (1). It
templates new insertions, many of which are 50
truncated or mutated at the time of insertion (gray
denotes inactivity). The new insertions segregate
mostly as neutral alleles; some accumulate to
a higher allele frequency over time (larger gray
circles in subsequent panels).
(B) A new insertion is generated that is highly
competent, or hot, for retrotransposition (2, blue).
This may be because of intrinsic sequence
features or its location in a region that permits
expression.
(C) This hot L1 templates others; theremay be a tendency to template other full-length, hot progeny insertions. Hot elements are continually lost through negative
selection (3, interrupted diagonal) or (D) mutation (2, interrupted arrow from C). However, some remain to potentiate other retrotransposition events (4). It is
envisioned that these hot elements are relatively transient in genomes due to purifying selection against them and do not achieve high allele frequency but are
responsible for the bulk of transposition in modern humans.(Ewing and Kazazian, 2011). Some of the same individuals were
independently analyzed for Alu indels by Hormozdiari et al. as
part of an eight person study (Hormozdiari et al., 2011). Although
limited in total numbers of people, this encompassed a broad
sampling of ethnicities, and sequencing coverage for each
person was relatively high, potentially explaining the identifica-
tion of 4,342 novel Alus with very high experimental validation
rates.
‘‘Second-generation’’ wet bench and in silico methods for
transposon discovery have gone beyond providing the promise
of a more complete catalog of common polymorphisms. They
have helped us to realize the level of mobile DNA activity in
modern humans. Several groups have used numbers of new
insertions discovered to estimate the rate of occurrence of non-
parental insertions that are thereafter heritable polymorphisms.
Xing et al. based their estimate on the number of nonreference
mobile DNA insertions found in Venter’s genome and used an
SNP-based clock measuring time to the most recent common
ancestor between Venter and the reference build. This led
them to the expectation that 1 in 21 people would have a new
Alu, 1 in 212 would have a new L1, and 1 in 916 would have
a new SVA (Xing et al., 2009). Using a similar calculation based
on TIP-chip, we estimated a rate of one de novo L1 insertion in
108 individuals (Huang et al., 2010). A distinct method of predict-
ing L1 polymorphism rates estimates 1 de novo L1 in 140 people
(Ewing and Kazazian, 2010). These transposition rate estimates
combined with population sizes can be used to project overall
numbers of human insertion alleles. For L1, this may be as
many as 12,000 insertions with allelic frequencies greater than
0.05. For Alu, a de novo insertion rate of 1 in 20 would result in
65,000 segregating insertions in populations of the same
frequency. Thus, we can expect that ‘‘common variant’’ RIP lists
will continue to grow in the near future.
A catalog of repeat polymorphisms, the dbRIP, is maintained
by Ping Liang and colleagues at Brock University (Wang et al.,
2006). Lengthier lists of common polymorphic transposon inser-
tions are a fundamental beginning, though it is important to
establish a contextual view of these genetic variants. These will
include integrating RIP sites with information about other sour-
ces of genetic variation (SNPs and structural variants) and epige-
netic states. Both should be promoted by the development of744 Cell 149, May 11, 2012 ª2012 Elsevier Inc.high-throughput RIP genotyping methods that are capable of
distinguishing homozygous and heterozygous states. Several
approaches for direct assays are in development, though
concerted efforts to find tagging SNPs of empty and filled alleles
may prove an effective alternative. We also speculate that intra-
repeat sequence polymorphisms—though overlooked by most
genetic variation studies today—will also gain consideration.
Active Transposons and Their Control
RIPs do not enter genomes to rest in peace. L1 and Alu continue
to expand their numbers in human genomes today, though the
pace of Alu accumulation may be slower than historical rates
(Britten, 1994; Shen et al., 1991). Insertions can serve as
templates for multiple ‘‘daughter’’ elements but can easily be
blocked from establishing themselves as active in populations
by either genetic drift or negative selection resulting in allele
loss or inactivation via mutation (Figure 4). As stressed above,
a narrowly defined set of repeat subfamilies is responsible for
sustaining all ongoing retrotransposition in humans. Several
recent studies indicate that, among the transposon groups
defined by sequence variation, a relatively small number of L1
and Alu elements drive the process.
Inactive L1 elements are frequently recognizable because they
are 50 truncated or have mutated open reading frames prevent-
ing production of functional ORF1p and ORF2p. Intact elements
are actively limited in genomes, and establishing a highly active
element in a population may be rare. Full-length L1(Ta)s are
subject to negative selection, and active onesmay be ephemeral
in populations (Boissinot et al., 2001, 2006). Among potentially
active L1(Ta) elements in the reference genome, in vitro retro-
transposition assays indicate that a relatively small group dispro-
portionally dominates aggregate transposition potential (Brouha
et al., 2003). Building on the observation of active, or ‘‘hot L1s,’’
in the reference genome, Beck et al. (2010) recently assayed
activity levels specifically in novel (nonreference) L1 insertions
in human populations. These relatively uncommon element
copies (i.e., low-frequency alleles) were recovered using a fosmid
paired-end DNA sequencing strategy to identify large indels.
Impressively, the majority of 68 full-length L1s found in fosmid
libraries from six individuals proved hot in culture. Although it
was expected that highly active elements would be responsible
for ongoing insertions of L1, Alu, and SVA, the observation
changed how we view the repository of L1 activity. It provides
evidence that each diploid genome—though harboring on
the order of a hundred competent L1s—has a complement of
hot elements. Each of the latter is relatively recently derived
(averaging about 1million years in age) and occurs with low allele
frequency. Themodel implies that, because the number of highly
active elements is so small, substantial individual variation in ret-
rotransposition activity may exist.
The level of similarity that a given L1 element shares with a hot
L1 consensus sequence can serve as a predictor of L1 activity
(Brouha et al., 2003). Exactly what the sequence variants are
with the most impact and their mechanisms of action may
provide insight into transposition mechanisms or host control.
It is possible to engineer super-active versions of human and
mouse L1 by recoding the open reading frames (An et al.,
2006; Han and Boeke, 2004). The synthetic murine-recoded
L1 (L1 ORFeus) exhibits 200-fold increased activity in in vitro
retrotransposition assays compared to its native counterpart.
In designing L1 ORFeus, we altered about one-quarter of the
nucleic acid sequence, changing codons to match the favored
trinucleotide usage of highly expressed mammalian genes.
This did not change ORF1p or ORF2p protein sequence and
was meant to mitigate DNA sequence features such as high
overall adenosine content, which may compromise transcrip-
tional readthrough of L1 (Han et al., 2004).
Distinct intrinsic and surrounding sequence features also influ-
ence the relative activity of Alu repeats. Network phylogenetic
approaches show that an oligopoly of ‘‘master’’ sequences is
responsible for the bulk of Alu element expansion, with each
active subfamily of Alu (Ya5a2, Ya8, Yb9, Yc1) having a singular
master template sequence that is central to its network of
daughter insertions. Though nearly 80% of the daughter inser-
tions appear to have directly derived from the master Alu,
a few sequences of each subfamily are further removed and
reflect activity of secondary source elements (Cordaux et al.,
2004). Studies of the AluYb subfamily add to this picture.
Although these elements are highly active in humans today, their
origins antedate rapid phases of their expansion by as much as
20 million years. This observation is the foundation for the
concept of ‘‘stealth drivers,’’ elements that are quiescent enough
to gain allelic frequency but are also capable of templating rela-
tively more active progeny (Han et al., 2005). Cis-acting factors
that are unique to the integration site seem especially critical
when considering the potential of any individual Alu sequence
for activity, including a requirement for 30 RNA Pol III terminator
sequences that are not encoded within the elements (Alema´n
et al., 2000).
Once inserted, transposons encounter host pressures at the
level of DNA sequence—selection favoring the empty allele
over the insertion allele or mutational inactivation of the trans-
poson—as well as pathways to repress mobile DNA insertions
through mechanisms such as RNA editing and epigenetic
silencing (Bogerd et al., 2006; Esnault et al., 2005; Muckenfuss
et al., 2006; Stenglein and Harris, 2006).
Epigenetic silencing relies on a variety of chromatin modifica-
tions. Among the best-studied host control mechanisms is
a specialized small RNA inhibition pathway that ultimatelycontrols de novo DNA methylation, repressing mobile DNA
expression in the male germline. Central are the Piwi-interacting
RNAs (piRNAs), short 26–31 nt long RNAs with similarity to
transposon control loci first characterized in Drosophila (Aravin
et al., 2006, 2007). Once piRNAs are generated from long
precursor RNAs, they are amplified and affect transposon
silencing in association with Piwi proteins. The amplification
involves piRNA-guided nuclease (slicer) activities of Piwi-like
homolog 1 (PIWIL1, also known as mouse Piwi [MIWI] or human
Piwi [HIWI], and PIWIL2 [Miwi-like (MILI)]) (De Fazio et al.,
2011; Kuramochi-Miyagawa et al., 2004; Reuter et al., 2011).
Interestingly, the catalytic endonuclease activity of PIWIL4
(also known as MIWI2 [mouse] or HIWI2 [human]) is dispensable
for amplification and piRNA-induced L1 LINE silencing, though
other MIWI2 functions are critical in transposon silencing.
MIWI2 RNPs contain piRNAs that are antisense to its transposon
targets (Aravin et al., 2008). In the nucleus, these MIWI2
complexes appear to directly cooperate with DNMT3L, to
regulate L1 methylation (Aravin et al., 2008; Bourc’his and
Bestor, 2004). Mice that are null for Miwi2 are male infertile
and show defects in spermatogenesis, with increased retro-
transposon RNAs and decreased methylation of genomic retro-
transposons, like animals lacking MIWI, MILI, or DNMT3L
activity (De Fazio et al., 2011; Kuramochi-Miyagawa et al.,
2004; Reuter et al., 2011) (Aravin et al., 2008; Bourc’his and Bes-
tor, 2004). Other Piwi-interacting proteins are also essential for
germline transposon silencing, including components of nuage
in spermatogonia and spermatocytes and the chromatoid body
in spermatids.
Co-operative roles of methyltransferases, DNMT1, DNMT3A,
and DNMT3B, are important for transposon methylation in
embryonic stem (ES) cells subsequent to de novo methylation
(Liang et al., 2002). In mouse ES cells, the enzymatic activity is
essential; targeted inactivation of DNMT1 methyltransferase
activity by point mutation leads to loss of intracisternal A-particle
(IAP) retrotransposon methylation and high IAP transcription
(Damelin and Bestor, 2007). Recently, in vitro retrotransposition
assays in human embryonic carcinoma cell (EC) lines show
that these pluripotent cells actively induce heterochromatin
formation in the vicinity of new transposon insertions in a
histone deacetylation-dependent manner. This feature is lost
upon cellular differentiation (Garcia-Perez et al., 2010). Though
not a physiologic cell type, the finding suggests that, like
early development in mouse, there may be key windows for
establishing retrotransposon repression in human development.
Further strengthening the connection between methylation and
retroelements silencing, Dnmt1 knockout mice are not viable,
and compound Dnmt1 heterozygotes, with one hypomorphic
and one null allele, develop thymic lymphomas (Gaudet et al.,
2003). These tumors exhibit genome-wide hypomethylation
and recurrent insertions of endogenous intracisternal A particles
(IAPs) at the Notch1 locus. Out of 16 lymphomas analyzed, 7
showed IAP insertions to activate theNotch1 oncogene (Howard
et al., 2008). Thus, loss of Dnmt1 provides susceptibility to
endogenous retrotransposon mutagenesis affecting differenti-
ated cells.
Another chromatin regulator important for somatic transposon
silencing in mice is lymphoid-specific helicase (LSH, also knownCell 149, May 11, 2012 ª2012 Elsevier Inc. 745
as HELLS), a member of the SNF2/helicase family of chromatin
remodelers. LSH coprecipitates with DNMT3A and DNMT3B
(Zhu et al., 2006) and with LINE, SINE, and IAP genomic loci
(Huang et al., 2004) in vitro. Lsh null mice die in the perinatal
period (Geiman et al., 2001) and exhibit hypomethylation of
LINEs, SINEs, and IAPs (Dennis et al., 2001) and derepressive
histone H3 and H4 acetylation marks in association with IAPs
(Huang et al., 2004). Hypomorphs are viable but suffer growth
defects and premature aging (Sun et al., 2004).
In addition to the piRNA-Piwi-based mechanism for control-
ling germline transposon silencing, recent studies have impli-
cated DICER-produced miRNAs as important to transposon
silencing in somatic cells. In a mouse model of age-related
macular degeneration, Cre-mediated mutation of Dicer specifi-
cally in retinal pigmented epithelium is accompanied byAlu-con-
taining RNA accumulation and a dependent cytotoxicity (Kaneko
et al., 2011). The study illustrates how repeat-containing RNAs
and small RNAs can be manipulated in experimental systems
and how this can provide important perspectives on conse-
quences of repeat expression. Note that expression of Alu
RNA, rather than retrotransposition per se, appears to be
disease causing. As we consider shortly, mobilome derepres-
sions in a host of human neoplasias have also described, though
their specific role in oncogenesis is not yet as defined.
Clearly, massive derepression of transposable elements can
have severe consequences, from crises in spermatogenesis to
complete loss of viability. Though most agree with the conven-
tional view that ongoing retrotransposition poses a hazard for
individual genomes (Dawkins, 1976), this perspective is being
challenged. Evidence of somatic retrotransposition in neurons
has led to the provocative proposal that such insertions might
endow specific populations of cells with beneficial unpreformed
genetic diversity, allowing for selection of phenotypes on
a cellular scale (Muotri et al., 2005). Leveraging a recently devel-
oped sequencing method that enriches for repeats through an
array capture, Faulkner and colleagues have found genomic
evidence to substantiate this model (Baillie et al., 2011). The
fact that these are extremely low abundance relative to germline
insertions—often identified as single junctional reads—suggests
that these somatic insertions are either cell specific or present in
tiny clonal lineages within normal neuronal tissue. Remarkably,
genes containing putative somatic intronic L1 insertions were
twice as likely to be differentially overexpressed in the brain, as
would be expected from random chance (Baillie et al., 2011).
This contrasts with random positioning of new insertions, which
was suggested by earlier low-throughput sequencing of L1 inte-
grations from in vitro retrotransposition assays. Whether tissues
besides brain exhibit this microchimerism is an evolving area,
though some studies have suggested the central nervous
system is a uniquely privileged environment for transposition.
How the Mobilome Matters
We have introduced the concepts that highly active transposons
show fitness costs associated with their intrinsic activities and
that active suppression of expressed repeats in the germline
and in somatic cells is vital in mice. In considering how the
human mobilome matters, we begin with the most straightfor-
ward examples of their roles in clinical genetics as insertional746 Cell 149, May 11, 2012 ª2012 Elsevier Inc.mutagens. In rare instances, a new insertion of L1, Alu, or SVA
hits a single locus in a cell that survives to compromise the func-
tion of that gene in an individual.
The first report of this described two independently occurring
L1 LINE insertions in two unrelated males with hemophilia A
(Kazazian et al., 1988). Both X chromosome insertions occurred
in exon 14 of the factor VIII gene, each preventing synthesis of
functional coagulation factor. Since that time, the literature has
accrued a series of similar case reports—13 L1, 33 Alu, and 4
SVA insertions causing a variety of conditions (reviewed in
Belancio et al., 2008; Chen et al., 2005; Ostertag and Kazazian,
2001a). Many of these cases resulted from directed studies of
a specific locus with a well-established role in disease. Most
known pathogenic insertions have been exonic such that critical
coding sequence is interrupted by the transposon itself. Exonic
disruptions associated with deletions or locus rearrangements
from transposon integration are less common. A total of 11 inser-
tion events involving exclusively intronic sequence are listed in
Table 1. Although this tally is short and skewed by ascertainment
methods such as exon-spanning gDNA PCRs, it is interesting to
note the propensity of pathogenic insertions near splice
acceptor sites at 30 intron/50 exon boundaries and the antisense
strand bias of such Alu repeats. Overall, these reports indicate
that transposon insertions provide recurrent but relatively
uncommonly sources of genetic mutation in humans. As new
sequencing technologies avail themselves in clinical genetics,
it will be interesting to see how our understanding of disease-
causing insertions changes. In this light, we mention a recent
report of an Alu insertion discovered through exome sequencing
in retinitis pigmentosa (Tucker et al., 2011). This is the first
example of a pathogenic transposon insertion ascertained by
next-generation sequencing, which is liable to exclude informa-
tive reads as unalignable. The authors describe this problem and
underscore the need to make exome sequencing analyses inclu-
sive of transposon insertions.
One pathogenic 30 UTR insertion ignites hope for altering the
natural history of genetic diseases caused by retroelement inser-
tions. This SVA insertion in the 30 UTR of the Fukutin gene causes
Fukuyama-type congenital muscular dystrophy (FCMD). FCMD
is one of the most common autosomal-recessive genetic
diseases in Japan, with an incidence of about 1 in 10,000; it
is diagnosed in early infancy and characterized clinically by
hypotonia, muscle weakness, and central nervous system
defects, including delayed mental development. It is a type of
a-dystroglycanopathy, with loss of O-glycosylation on this cell
membrane protein, that mediates interactions with extracellular
matrix. Discovered in 1998, the causative 3 kb sense-oriented
SVA insertion is a component of the FCMD founder haplotype
seen in 87% of FCMD cases and carried by about 1 out of
88 Japanese individuals (Kobayashi et al., 1998). The insertion
induces a splice donor site within the last exon of Fukutin
and exonizes part of the SVA; there is a replacement of the
end of the normal open reading frame (coding 38 C-terminal
AA) with coding sequence for 129AA. Excitingly, in cell culture
and in a murine model of the disease, these effects can be
mitigated and normal splicing restored by the addition of a
combination of 25 mer 20-O-methyl phosphoramidite (20OMePS)
antisense oligonucleotides targeted to the aberrant splice
Table 1. Pathologic Intronic Insertions in Humans
Retroelement Length Orientation Position in Gene Gene Name Abbreviation Phenotype mRNA Studies Reference
Alu
AluYc1 316 bp antisense 52 bp from the
30 end of intron 4
glycerol kinase GK benign isolated
glycerol kinase
deficiency
not reported (Zhang et al., 2000)
AluYb9 330 bp antisense 19 bp from the
30 end of intron 18
coagulation factor VIII F8 hemophilia A exon 19 skipping (Ganguly et al., 2003)
AluYa5 331 bp antisense 50 bp from the







exon 8 skipping (Tighe et al., 2002)
AluYa5 368 bp antisense 19 bp from the
30 end of intron 8
fibroblast growth factor
receptor 2
FGFR2 Apert syndrome ectopic exon 7/8
splicing in lieu of 7/9
(Oldridge et al., 1999)
AluYa5 320 bp antisense 44 bp from the





exon 6 skipping (Wallace et al., 1991)
L1
L1(Ta) 836 bp sense and
rearranged








(Meischl et al., 2000)
L1(Ta) 6 kb antisense reported as 30
end of intron 2
hemoglobin, b HBB b-thalasemia not reported (Kimberland et al., 1999)
L1(Ta) 1.2 kb sense 24 bp from the




variable exon 7, 8,
and 9 skipping
(Kondo-Iida et al., 1999)





(Schwahn et al., 1998)
L1(Ta) 2.8 kb antisense and
rearranged
8 bp from the





exon 4 skipping (Martı´nez-Garay et al., 2003)
SVA
SVA 2.6 kb sense intron 1 low-density lipoprotein







































acceptor, donor, and exonic splicing enhancer sites (Taniguchi-
Ikeda et al., 2011).
Effects on gene function of fixed insertions or commonly
occurring RIPs is an active area of ongoing research. Our
working model is that mammalian repeats can act as ‘‘soft’’
genetic variants damping levels of gene expression or altering
transcript structure to partial degrees and in context-dependent
manners. In the case of L1, premature polyadenylation and
compromised RNA polymerase elongation are two well-
described mechanisms for this (Chen et al., 2006; Han and
Boeke, 2005; Han et al., 2004; Perepelitsa-Belancio and Dein-
inger, 2003). For example, sense orientation insertions of the
ORF2-encoding portions of L1 into a reporter gene intron low-
ered both RNA and protein production sharply, reflecting atten-
uated transcript elongation through the adenosine-rich strand,
an effect that is not sequence specific but can be recapitulated
with other L1 portions when present in sufficient total length
(Han and Boeke, 2005). Insertion in the antisense orientation
produced a decrease in full-length RNA that was less
pronounced, and this could be ascribed primarily to prematurely
polyadenylated forms. The nonrandomorientation of intronic L1s
in our genome with respect to their encompassing genes
suggests that these findings are relevant for understanding the
impact of these elements in the human genome. L1s within tran-
script units show a biased antisense orientation, consistent with
a more deleterious role of sense insertions and thus stronger
negative selection. This effect is appreciable in young, low allele
frequency L1(Ta) but increasingly pronounced if older, fixed
L1(Ta) or older pre-Ta L1 elements are considered (Huang
et al., 2010). This said, there is a dearth of specific RIPs that
affect genes in known and consequential ways. An Alu indel at
the angiotensin-I-converting enzyme (ACE) locus is the best-
studied candidate, given its association with serum enzyme
levels (Rigat et al., 1990). But how this intronic insertion func-
tions, or whether it is more than a proxy for some other variant,
is yet unclear.
Transcriptome studies will likely demonstrate the functional
impact of repeats on gene transcripts. Examples have been
shown in traditional methods (Rangwala et al., 2009; Speek,
2001) and may be hugely bolstered by new sequencing technol-
ogies. Faulkner et al. recently performed cap analysis gene
expression (CAGE) experiments sequencing 20 and 21 nt tags
from the 50-most ends of transcripts in a variety of mouse and
human cells. The authors imposed a hierarchical alignment
strategy in attempts to unequivocally assign genomic positions
to each tag; ‘‘multimapping’’ tags in which there is ambiguity in
the site comprised a minority of aligned reads. Transcript start
sites (TSSs) were recognized once mapped with at least two
congruous tags. A total of 275,185 TSSs in human cells, repre-
senting 31.4% of all TSSs, showed homology to repeats. The
majority, about 214,000, corresponded specifically to transpos-
able elements. Their data also suggest a high degree of spatio-
temporal specificity and correlation between transposon-
initiated transcription and expression of proximal genes. This
suggests that coregulation of repeats and neighboring loci
supersedes transcriptional interference.
Neoplastic conditions will rightly receive special attention as
functional impacts of the human mobilome are approached748 Cell 149, May 11, 2012 ª2012 Elsevier Inc.(see review by Belancio et al., 2010). L1 hypomethylation in
tumors is well described in many tumor types, including breast
(Alves et al., 1996), colon (Dante et al., 1992; Este´cio et al.,
2007; Suter et al., 2004), and prostate cancers (Cho et al.,
2007; Santourlidis et al., 1999; Schulz et al., 2002) to cite
a few. In the case of the latter, hypomethylation of L1 associated
with preoperative prostate-specific antigen levels, histopatho-
logic measures of aggression (Gleason grade), and anatomic
spread of the tumor (clinical stage); it also associated indepen-
dently with cytogenetic abnormalities. Reagents for assaying
protein expression of L1 ORF1p and ORF2p are not developed
to the point of being useful clinical markers, though ORF1p
expression has been reported in breast cancer cases. Here,
a nuclear staining pattern is reported to correlate positively
with incidence of both local recurrence and distal metastases
and with worse overall survival (Harris et al., 2010). Repeat dere-
pression in tumors can be envisioned to have several sequelae.
One may be complete retrotransposition cycles, generating
somatic L1, Alu, and SVA insertions that are specific to the
neoplastic lineage. It is known that somatic insertions that are
relevant to cellular transformation can occur. In a case of colon
cancer, a somatic L1(Ta) insertion has been found interrupting
an exon of the adenomatous polyposis coli (APC) tumor
suppressor locus (Miki et al., 1992). Recently, the Devine labora-
tory has described somatic insertions in cases of lung cancer
revealed through next-generation sequencing of L1 and Alu
insertion sites, though retroelement-induced driver mutations
have not been described (Iskow et al., 2010). Interestingly, their
work suggests that somatic insertions may be tumor tissue type
specific and, evenwithin a broad neoplastic category, may occur
selectively in tumors with an epigenetic signature of differentially
methylated gene loci. How well existing clinical diagnostic
criteria have captured information about L1 activity will be inter-
esting to understand as these studies go forward. In considering
othermechanisms, L1-encodedORF2p expression can promote
DNA breaks and even perhaps specific chromosomal transloca-
tions (Lin et al., 2009) independently from completed mobile
element insertion. Finally, effects on neighboring gene loci may
be important aspects to understand. Specific L1 antisense-initi-
ated transcripts can act as oncogenes (Roman-Gomez et al.,
2005; Weber et al., 2010). More broadly, Este´cio and colleagues
recently recognized that gene promoters with high transposon
content are also relatively resistant to methylation in cancer cell
lines and maintain higher gene expression levels as compared
to promoters with fewer interspersed repeats (Este´cio et al.,
2010). These data suggest that transposable element-directed
epigenetic studies that are capable to describe the status of
individual elements (fixed and polymorphic) will be valuable to
integrate with our current picture of the cancer cell genome.
Concluding Remarks
High copy number, self-propagating repeats are landscape-
determining components of our DNA. Many are fixed, static,
and slowly eroding features, but there are also focal ‘‘hot
spots’’—elements that demonstrate episodic activity and sites
where new insertions can be found. Today, new technologies
are being developed to reveal insertions, confirming that inter-
spersed repeat polymorphisms are important sources of genetic
variation in human populations and suggesting that each of us
has somatic compartments genetically variegated by insertion
events. Many models of how repeats may influence human
phenotypes are emerging, and we look forward to delineating
and altering functions of specific insertions in human disease.
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